A cluster randomised trial evaluating the clinical effectiveness and cost of telemedicine delivered multidisciplinary meetings in breast cancer
ISRCTN | ISRCTN67592929 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN67592929 |
Secondary identifying numbers | 1217319 |
- Submission date
- 13/09/2005
- Registration date
- 11/11/2005
- Last edited
- 09/05/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Ian Kunkler
Scientific
Scientific
Oncology Department
Western General Hospital
Crewe Road South
Edinburgh
EH4 2XU
United Kingdom
Phone | +44 (0)131 537 2213 |
---|---|
iankunkler@yahoo.com |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | |
Study acronym | TELEMAM |
Study objectives | Decision making in breast cancer management at a multidisciplinary team (MDT) meeting is as clinically effective as face-to-face meetings and achieved at lower cost. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Breast cancer |
Intervention | Randomised standard face-to-face 'on site' multidisciplinary meetings for breast cancer management (MDTs) at Dumfries and Dunfermline (Arm 1) versus MDTs on Dumfries and Dunfermline patients linked by telemedicine between Dumfries and Edinburgh, and Dunfermline and Edinburgh (Arm 2). |
Intervention type | Other |
Primary outcome measure | 1. Satisfaction with communication process of multidisciplinary decision making for each patient (Interpersonal Communication Satisfaction Scale) 2. Costs of face-to-face and telemedicine delivered decision making 3. Compliance with Scottish Intercollegiate Guidelines Network (SIGN) guidelines of best practice for breast cancer |
Secondary outcome measures | 1. Pre- and post-trial attitudes to face-to-face and telemedicine delivered multidisciplinary clinics (Personal Report of Communication Apprehension) 2. Measures of objective patterns of interaction 3. Subjective measures of interaction (Group Behaviour Questionnaire, Group Behaviour Inventory, Group Dimensions Description Questionnaire) 4. Communication content (Interaction Process Analysis) 5. General dimensions of output (satisfaction with communication, group atmosphere, involvement, trust and agreement) |
Overall study start date | 24/04/2003 |
Completion date | 31/07/2005 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Female |
Target number of participants | 230 |
Key inclusion criteria | 1. Histologically proven breast cancer 2. Requiring decision on treatment of primary or recurrent breast cancer |
Key exclusion criteria | Does not match inclusion criteria |
Date of first enrolment | 24/04/2003 |
Date of final enrolment | 31/07/2005 |
Locations
Countries of recruitment
- Scotland
- United Kingdom
Study participating centre
Oncology Department
Edinburgh
EH4 2XU
United Kingdom
EH4 2XU
United Kingdom
Sponsor information
UK Department of Health Research and Development
Government
Government
Dr R Curry and Mr W Maton-Howarth
Department of Health Research and Development
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)207 210 4850 |
---|---|
richard.curry@imperial.ac.uk | |
Website | http://www.dh.gov.uk |
Funders
Funder type
Government
Department of Health (UK) - Research and Development
No information available
Big Lottery Fund (UK)
Private sector organisation / Other non-profit organizations
Private sector organisation / Other non-profit organizations
- Alternative name(s)
- BIG
- Location
- United Kingdom
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Protocol article | protocol | 01/10/2005 | Yes | No | |
Results article | results | 01/11/2007 | Yes | No |